US Spatial Genomics and Transcriptomics Market Size Worth $360.96 million by 2034 | CAGR: 12.7%

The US spatial genomics and transcriptomics market size is expected to reach USD 360.96 million by 2034, according to a new study by Polaris Market Research. The report “US Spatial Genomics and Transcriptomics Market Size, Share, Trends, Industry Analysis Report – By Technology, Product, End Use (Translational Research, Academic Customers, Diagnostic Customers, Pharmaceutical Manufacturer); Market Forecast, 2025-2034” gives a detailed insight into current market dynamics and provides analysis of future market growth.

The US spatial genomics and transcriptomics market is experiencing significant growth, driven by advances in precision medicine, increasing research into complex diseases, and the widespread adoption of spatial technologies in both academic and clinical settings. These technologies allow researchers to analyze gene expression and tissue architecture with high spatial resolution, offering critical insights into diseases such as cancer, Alzheimer's, and diabetes. Additionally, the market is supported by substantial investments from government agencies such as the NIH, as well as private sector funding. The demand for spatial genomics in drug development, biomarker discovery, and translational research is fueling market expansion, with both academic institutions and pharmaceutical companies leading the charge.

For instance, in March 2024, a study published in Environmental and Molecular Medicine conducted a review of multi- and single-cell omics for detailed molecular profiling. They also explored the applications of single-cell and multi-omics in cancer, precision medicine, neurobiology, and immunology.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below: https://www.polarismarketresearch.com/industry-analysis/us-spatial-genomics-and-transcriptomics-market/request-for-sample

The increasing use of high-throughput sequencing technologies provides a significant opportunity by enabling rapid and thorough analysis of genetic material in various tissue types. This is especially beneficial for studying complex diseases at the molecular level and helps in identifying new therapeutic targets. Additionally, advances in ‘inn situ’ sequencing and imaging techniques are expanding the capability to directly visualize gene expression within tissues, providing deeper insights into cellular behavior. These innovations, along with growing collaborations between academia, pharmaceutical companies, and healthcare institutions, are fueling the development of new spatial genomics tools, ultimately speeding up progress in personalized medicine and precision therapies.

US Spatial Genomics and Transcriptomics Market Report Highlights

• In 2024, the spatial transcriptomics segment dominated the market in the US due to its advanced capabilities in analyzing gene expression with a high spatial resolution that offers a powerful method for creating spatial maps of complex tissues, which is crucial for understanding tissue architecture and disease mechanisms.
• The consumables segment accounted for the largest market share in 2024 due to the widespread adoption of consumables and items, including reagents, kits, and sample preparation materials, which are essential for performing a wide range of procedures and analyses.
• The translational research segment dominates the US spatial genomics and transcriptomics market due to its critical role in bridging basic science with clinical applications
• The global players include 10X Genomics, Akoya Biosciences, Bio-Rad Laboratories, Bio-Techne, BioSpyder Technologies, Cantata Bio, & Danaher Corporation.

Polaris Market Research has segmented the US spatial genomics and transcriptomics market report based on product, technology, application, and end use:

US Spatial Genomics & Transcript Market Segmentation

Product Outlook (Revenue, USD Million, 2020 - 2034)

• • Instruments
    • By Mode
      • Automated
      • Semi-automated
      • Manual
    • By Type
      • Sequencing Platforms
      • IHC
      • Microscopy
      • Flow Cytometry
      • Mass Spectrometry
      • Others
  • Consumables
  • Software
    • Bioinformatics Tools
    • Imaging Tools
    • Storage and Management Databases

Technology Outlook (Revenue, USD Million, 2020 - 2034)

• • Spatial Transcriptomics
    • Sequencing-Based Methods
      • Laser Capture Microdissection (LCM)
        • FFPE Tissue Samples
        • Others
      • Transcriptome In-Vivo Analysis (TIVA)
      • In Situ Sequencing
      • Microtomy Sequencing
    • IHC
    • Microscopy-based RNA Imaging Techniques
      • Single Molecule RNA Fluorescence In-Situ Hybridization (smFISH)
      • Padlock Probes/ Rolling Circle Amplification
      • Branched DNA Probes
  • Spatial Genomics
    • FISH
    • Microscopy-based Live DNA Imaging
    • Genome Perturbation Tools
    • Massively-Parallel Sequencing
    • Biochemical Techniques
    • Others

End Use Outlook (Revenue, USD Million, 2020 - 2034)

• • Translational Research
  • Academic Customers
  • Diagnostic Customers
  • Pharmaceutical Manufacturer

U.S. Spatial Genomics & Transcriptomics Market Report Scope